Accredited Industry-Supported Symposia: A New Era in Diabetic Foot Management: The Science, Evidence, and Clinical Application of OFM-Hyaluronic Acid Technology

HMP Education has designated an unrestricted grant from Aroa Biosurgery for this session.

Learning objectives:
1. Review current evidence-based management strategies for complex diabetic foot ulcers and discuss evolving challenges and opportunities to improve patient outcomes.
2. Explain the complementary mechanisms of action of ovine forestomach matrix (OFM) and hyaluronic acid (HA), including their roles in modulating inflammation, supporting tissue regeneration, and promoting healing in diabetic foot ulcers (DFUs).
3. Evaluate the current clinical evidence supporting OFM-HA technology for lower extremity reconstruction and diabetic foot ulcer management, including findings from randomized controlled trials.
4. Apply evidence-based strategies for incorporating OFM-HA technology into individualized treatment plans for patients with diabetic foot ulcers through case-based discussions.
5. Integrate clinical, operational, and reimbursement considerations into the adoption of OFM-HA technology.